Grant: Discovery Grants Program - Individual
University of Manitoba
$40,000.00
Characterization of HYAL2 and non-HYAL2 dependent pathways of hyaluronan degradation
FY 2017-18
Summary
Hyaluronan (HA) is a polysaccharide that is essential tothe structure and function of the matrixsurrounding vertebrate cells. There is 15 g of HA present in anaverage adult human, 1/3 of which is replaced each day through constitutive turnover. In addition HA is increased when cells multiply and migrate and decreased when cells mature through regulated HA turnover. Three widely expressed hyaluronidase enzymes (HYALs) that degrade HA and three receptors that bind and internalize HA have been identified, but how they contribute to HAdegradation is poorly understood. OBJECTIVES The long term objective of my laboratory is to determine how three HYAL enzymes (HYAL1, HYAL2, HYAL3) work with HA receptors to mediate HA degradation.In the currentmodel for HA degradation,HYAL2is proposed to cleaveextracellular HAto fragments that areinternalizedfor degradation in the lysosome. Consistent with this,mice lacking HYAL2(HYAL2 KO)accumulate extracellular HA. However, HYAL2 activity is not reproducibly detected. Further,cells from HYAL2 KOmice internalize and degrade HA. Based on these findings, we hypothesize that HYAL2 is an HA-degrading enzyme whose activity is regulated, and that non-HYAL2 dependent pathways of HA degradation exist .Myimmediate goals (next 5 years) to address this hypothesis are: 1. To determine if HYAL2 functions as a HA-degrading enzyme and/or receptor.The size of HA and whetherit is internalized in the presence of wild type or mutant forms of HYAL2 expressed in HYAL2 KO cells will be examined.Increased HA sizein the presence of mutant HYAL2will suggestHYAL2 is anenzyme. If activity for HYAL2 is demonstrated, we will develop novel assays for HYAL2 activity by mass spectrometry and/or using HA protein complexes to replace exogenousHA. 2. To identify HYAL2 binding proteins that can modulate its activity.Interacting partners for HYAL2 will be identified from developing mouse hearts using immunoprecipitation followed by mass spectrometry. Confirmed interacting partners will be overexpressed in wild type and HYAL2 KO cells and HA size, HYAL2 activity, and HA internalization, will be examined. 3. To identify and differentiate pathways of HA degradation.Uptake of fluorescentHAby wild type and Hyal2 KOcells will be monitoredin the presence and absence ofinhibitors ofinternalization pathways, and/or blocking antibodies for known HA receptors.Pathways identified in vitro will be verified in vivo by monitoring the uptake of fluorescently labelled HAby optical imaging. SIGNIFICANCE With my HQP, wewill advancethe understanding of HA degradation while giving HQPvaluable skills in glycoscience thatareneeded byindustriesusing HA incosmetic, veterinary and tissue engineering applications.HYAL2,or its activators, are likely tobe identified as valuable targets by these industries for the development ofinhibitors that could increase thehalf lifeofexogenous HA products.
Program
Discovery Grants Program - Individual
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2017-04953
Name nom
TriggsRaine, Barbara
Department département
Biochemistry and Medical Genetics - Biochemistry and Medical Genetics
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
40000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5106
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Extra-cellular matrix
Research subject fr
Matrice extra-cellulaire
Partie
1
Nb partie
5
Application title
Characterization of HYAL2 and non-HYAL2 dependent pathways of hyaluronan degradation
Keyword
NSERC
Application summary
Hyaluronan (HA) is a polysaccharide that is essential tothe structure and function of the matrixsurrounding vertebrate cells. There is 15 g of HA present in anaverage adult human, 1/3 of which is replaced each day through constitutive turnover. In addition HA is increased when cells multiply and migrate and decreased when cells mature through regulated HA turnover. Three widely expressed hyaluronidase enzymes (HYALs) that degrade HA and three receptors that bind and internalize HA have been identified, but how they contribute to HAdegradation is poorly understood. OBJECTIVES The long term objective of my laboratory is to determine how three HYAL enzymes (HYAL1, HYAL2, HYAL3) work with HA receptors to mediate HA degradation.In the currentmodel for HA degradation,HYAL2is proposed to cleaveextracellular HAto fragments that areinternalizedfor degradation in the lysosome. Consistent with this,mice lacking HYAL2(HYAL2 KO)accumulate extracellular HA. However, HYAL2 activity is not reproducibly detected. Further,cells from HYAL2 KOmice internalize and degrade HA. Based on these findings, we hypothesize that HYAL2 is an HA-degrading enzyme whose activity is regulated, and that non-HYAL2 dependent pathways of HA degradation exist .Myimmediate goals (next 5 years) to address this hypothesis are: 1. To determine if HYAL2 functions as a HA-degrading enzyme and/or receptor.The size of HA and whetherit is internalized in the presence of wild type or mutant forms of HYAL2 expressed in HYAL2 KO cells will be examined.Increased HA sizein the presence of mutant HYAL2will suggestHYAL2 is anenzyme. If activity for HYAL2 is demonstrated, we will develop novel assays for HYAL2 activity by mass spectrometry and/or using HA protein complexes to replace exogenousHA. 2. To identify HYAL2 binding proteins that can modulate its activity.Interacting partners for HYAL2 will be identified from developing mouse hearts using immunoprecipitation followed by mass spectrometry. Confirmed interacting partners will be overexpressed in wild type and HYAL2 KO cells and HA size, HYAL2 activity, and HA internalization, will be examined. 3. To identify and differentiate pathways of HA degradation.Uptake of fluorescentHAby wild type and Hyal2 KOcells will be monitoredin the presence and absence ofinhibitors ofinternalization pathways, and/or blocking antibodies for known HA receptors.Pathways identified in vitro will be verified in vivo by monitoring the uptake of fluorescently labelled HAby optical imaging. SIGNIFICANCE With my HQP, wewill advancethe understanding of HA degradation while giving HQPvaluable skills in glycoscience thatareneeded byindustriesusing HA incosmetic, veterinary and tissue engineering applications.HYAL2,or its activators, are likely tobe identified as valuable targets by these industries for the development ofinhibitors that could increase thehalf lifeofexogenous HA products.